Endocannabinoids and Schizophrenia
The endocannabinoids anandamide and 2-arachydonoylglycerol (2-AG) are lipids naturally derived from membrane precursors which bind cannabinoid receptors (CB1, CB2). This endocannabinoid system is disturbed in schizophrenia. Indeed, there seems to be an association between schizophrenia and polymorph...
Saved in:
Main Authors: | Stéphane Potvin (Author), Lahcen Ait Bentaleb (Author), Emmanuel Stip (Author), Joëlle Desfoss��s (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2010-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New Perspectives in the Studies on Endocannabinoid and Cannabis: Cannabinoid Receptors and Schizophrenia
by: Hiroshi Ujike, et al.
Published: (2004) -
Alterations of the endocannabinoid system and circulating and peripheral tissue levels of endocannabinoids in sarcopenic rats
by: Olivier Le Bacquer, et al.
Published: (2022) -
A randomized-controlled trial with a Canadian electronic pill dispenser used to measure and improve medication adherence in patients with schizophrenia
by: Emmanuel eStip, et al.
Published: (2013) -
Cannabis and Endocannabinoid System
by: Somchai Amornyotin
Published: (2021) -
Endocannabinoids and Human Sperm Cells
by: Giovanna Zolese, et al.
Published: (2010)